Evolent Health 2024年第四季度每股亏损$(0.02),低于$0.01预期,营收$6.465亿低于$6.5119亿预期

财报速递2025-02-21
Evolent Health (NYSE:EVH) 公布了其季度每股亏损$(0.02),低于分析师一致预期的$0.01,相差300%。与去年同期每股收益$0.23相比下降了108.7%。公司报告的季度营收为$6.465亿,低于分析师一致预期的$6.5119亿,相差0.72%。不过,与去年同期的营收$5.5605亿相比增长了16.27%。

以上内容来自Benzinga Earnings专栏,原文如下:

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.01 by 300 percent. This is a 108.7 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $646.50 million which missed the analyst consensus estimate of $651.19 million by 0.72 percent. This is a 16.27 percent increase over sales of $556.05 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法